Halozyme Therapeutics
HALO
#1703
Rank
A$17.92 B
Marketcap
A$157.90
Share price
2.73%
Change (1 day)
45.51%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): A$0.85 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.66 Billion. In 2025 the company made an earning of A$0.67 Billion a decrease over its 2024 earnings that were of A$0.80 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.85 B27.17%
2025 A$0.67 B-16.2%
2024 A$0.80 B59.94%
2023 A$0.50 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$88.55 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$46.33 Million-52.86%
2014 -A$98.28 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$76.98 Million169.94%
2011 -A$28.52 Million-63.44%
2010 -A$77.99 Million-7.19%
2009 -A$84.03 Million15.91%
2008 -A$72.49 Million83.89%
2007 -A$39.43 Million78.1%
2006 -A$22.14 Million16%
2005 -A$19.09 Million45.24%
2004 -A$13.14 Million682.42%
2003 -A$1.68 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.66 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.92 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.28 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.29 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.7 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$69.94 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA